High materiality7/10
Biogen price target raised to $224 from $206 at Morgan Stanley
Why it may matterVerify against the original reporting
target_raised
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Biogen price target to $224; posted price $198.67.
- Morgan Stanley raises BIIB PT to $224; price $198.67.
Key facts
- 01
Target: $224
- 02
Posted price: $198.67
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.